Supermax Corporation Berhad
Supermax Corporation Berhad, an investment holding company, manufactures, distributes, and markets medical gloves and contact lenses in Europe, North America, Central America, South America, Asia, Oceania, and Africa. It operates through four segments: Investment Holding, Manufacturing of Gloves, Trading of Gloves, and Others. The company offers various types of nitrile latex and natural rubber g… Read more
Supermax Corporation Berhad (SPMXF) - Net Assets
Latest net assets as of December 2025: $3.81 Billion USD
Based on the latest financial reports, Supermax Corporation Berhad (SPMXF) has net assets worth $3.81 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.16 Billion) and total liabilities ($342.34 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.81 Billion |
| % of Total Assets | 91.76% |
| Annual Growth Rate | 17.07% |
| 5-Year Change | -16.38% |
| 10-Year Change | 302.22% |
| Growth Volatility | 49.67 |
Supermax Corporation Berhad - Net Assets Trend (2007–2025)
This chart illustrates how Supermax Corporation Berhad's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Supermax Corporation Berhad (2007–2025)
The table below shows the annual net assets of Supermax Corporation Berhad from 2007 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $4.09 Billion | -8.87% |
| 2024-06-30 | $4.49 Billion | -4.27% |
| 2023-06-30 | $4.69 Billion | -6.77% |
| 2022-06-30 | $5.03 Billion | +2.81% |
| 2021-06-30 | $4.89 Billion | +215.66% |
| 2020-06-30 | $1.55 Billion | +36.70% |
| 2019-06-30 | $1.13 Billion | +10.90% |
| 2018-06-30 | $1.02 Billion | -4.44% |
| 2017-06-30 | $1.07 Billion | +5.18% |
| 2016-06-30 | $1.02 Billion | +7.78% |
| 2015-06-30 | $944.08 Million | +5.17% |
| 2014-06-30 | $897.65 Million | +7.66% |
| 2013-06-30 | $833.78 Million | +8.42% |
| 2012-06-30 | $769.04 Million | +11.21% |
| 2011-06-30 | $691.52 Million | +23.74% |
| 2010-06-30 | $558.83 Million | +34.21% |
| 2009-06-30 | $416.38 Million | +8.49% |
| 2008-06-30 | $383.79 Million | +59.98% |
| 2007-06-30 | $239.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Supermax Corporation Berhad's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 404150800000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $4.04 Billion | 99.06% |
| Common Stock | $340.08 Million | 8.34% |
| Other Comprehensive Income | $-131.52 Million | -3.22% |
| Total Equity | $4.08 Billion | 100.00% |
Supermax Corporation Berhad Competitors by Market Cap
The table below lists competitors of Supermax Corporation Berhad ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LENZ Therapeutics Inc
NASDAQ:LENZ
|
$250.65 Million |
|
Lumax International Corp Ltd
TW:6192
|
$250.66 Million |
|
Shijiazhuang Kelin Elec Co
SHG:603050
|
$250.69 Million |
|
Jamna Auto Industries Limited
NSE:JAMNAAUTO
|
$250.73 Million |
|
XP Power Limited
PINK:XPPLF
|
$250.56 Million |
|
PONCE FIN. GROUP DL -01
F:73V0
|
$250.54 Million |
|
Piraeus Port Authority S.A
AT:PPA
|
$250.51 Million |
|
Shandong Luyang Share Co Ltd
SHE:002088
|
$250.45 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Supermax Corporation Berhad's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,473,802,000 to 4,079,790,000, a change of -394,012,000 (-8.8%).
- Net loss of 160,396,000 reduced equity.
- Share repurchases of 12,912,000 reduced equity.
- Other comprehensive income decreased equity by 220,248,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-160.40 Million | -3.93% |
| Share Repurchases | $12.91 Million | -0.32% |
| Other Comprehensive Income | $-220.25 Million | -5.4% |
| Other Changes | $-456.00K | -0.01% |
| Total Change | $- | -8.81% |
Book Value vs Market Value Analysis
This analysis compares Supermax Corporation Berhad's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.11x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.25x to 0.11x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-06-30 | $0.12 | $0.15 | x |
| 2008-06-30 | $0.19 | $0.15 | x |
| 2009-06-30 | $0.18 | $0.15 | x |
| 2010-06-30 | $0.25 | $0.15 | x |
| 2011-06-30 | $0.24 | $0.15 | x |
| 2012-06-30 | $0.26 | $0.15 | x |
| 2013-06-30 | $0.29 | $0.15 | x |
| 2014-06-30 | $0.33 | $0.15 | x |
| 2015-06-30 | $0.35 | $0.15 | x |
| 2016-06-30 | $0.38 | $0.15 | x |
| 2017-06-30 | $0.40 | $0.15 | x |
| 2018-06-30 | $0.39 | $0.15 | x |
| 2019-06-30 | $0.43 | $0.15 | x |
| 2020-06-30 | $0.59 | $0.15 | x |
| 2021-06-30 | $1.83 | $0.15 | x |
| 2022-06-30 | $1.84 | $0.15 | x |
| 2023-06-30 | $1.75 | $0.15 | x |
| 2024-06-30 | $1.45 | $0.15 | x |
| 2025-06-30 | $1.32 | $0.15 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Supermax Corporation Berhad utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.93%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -20.51%
- • Asset Turnover: 0.18x
- • Equity Multiplier: 1.08x
- Recent ROE (-3.93%) is below the historical average (15.53%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 16.57% | 9.93% | 0.77x | 2.18x | $15.76 Million |
| 2008 | 14.58% | 9.74% | 0.66x | 2.26x | $17.57 Million |
| 2009 | 11.29% | 5.79% | 0.86x | 2.27x | $5.36 Million |
| 2010 | 22.65% | 15.75% | 0.85x | 1.69x | $70.70 Million |
| 2011 | 22.99% | 16.26% | 0.92x | 1.54x | $89.79 Million |
| 2012 | 13.54% | 10.20% | 0.85x | 1.57x | $27.25 Million |
| 2013 | 14.59% | 12.20% | 0.80x | 1.50x | $38.31 Million |
| 2014 | 13.32% | 11.42% | 0.76x | 1.54x | $29.85 Million |
| 2015 | 10.12% | 9.52% | 0.69x | 1.55x | $1.13 Million |
| 2016 | 9.28% | 9.15% | 0.63x | 1.61x | $-7.37 Million |
| 2017 | 6.30% | 5.96% | 0.63x | 1.68x | $-39.52 Million |
| 2018 | 10.53% | 8.18% | 0.77x | 1.68x | $5.39 Million |
| 2019 | 10.96% | 8.00% | 0.83x | 1.64x | $10.74 Million |
| 2020 | 34.32% | 24.62% | 0.66x | 2.11x | $371.89 Million |
| 2021 | 80.20% | 53.27% | 0.97x | 1.55x | $3.34 Billion |
| 2022 | 14.78% | 26.75% | 0.45x | 1.22x | $232.35 Million |
| 2023 | -3.06% | -17.16% | 0.16x | 1.14x | $-601.01 Million |
| 2024 | -3.91% | -27.09% | 0.13x | 1.09x | $-622.41 Million |
| 2025 | -3.93% | -20.51% | 0.18x | 1.08x | $-568.38 Million |
Industry Comparison
This section compares Supermax Corporation Berhad's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Supermax Corporation Berhad (SPMXF) | $3.81 Billion | 16.57% | 0.09x | $250.64 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |